Indication

Myxedema

Myxedema refers to an advanced clinical state of severe hypothyroidism, as well as the characteristic dermatologic change resulting from profound thyroid hormone deficiency. Read more about Myxedema

3 drugs 3 manufacturers

Advertisement

Drugs that treat it

Common Myxedema therapies.

Showing 1–3 of 3 drugs

Filter & compare in the drug finder →Opens the drug finder with Myxedema preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Myxedema.

Myxedema refers to an advanced clinical state of severe hypothyroidism, as well as the characteristic dermatologic change resulting from profound thyroid hormone deficiency.

It primarily impacts the endocrine and integumentary systems, frequently affecting adult populations—especially older individuals and women with long-standing or inadequately managed thyroid disease.

Pathophysiologically, sustained thyroid hormone insufficiency promotes widespread interstitial accumulation of hydrophilic glycosaminoglycans, leading to mucinous nonpitting edema, facial puffiness, coarse dry skin, and broad metabolic slowing.

Without intervention, this systemic hypometabolic state can deteriorate into myxedema coma, a critical medical emergency marked by hypothermia, profound lethargy or altered sensorium, bradycardia, and multiorgan decompensation.

Personalize your experience

Follow Myxedema and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it